We advance neoantigen discovery with high-resolution, clinically-driven mass spectrometry workflows.
NeoMass Biotech is dedicated to advancing neoantigen discovery through state-of-the-art mass spectrometry. We integrate high-resolution proteomics, immunopeptidomics, and bioinformatics to identify tumor-specific antigens with precision and speed. Our platform empowers personalized cancer immunotherapy by delivering robust, clinically relevant neoantigen profiles for vaccine design, cell therapies, and biomarker development. With rigorous quality control and translational expertise, NeoMass Biotech accelerates the path from discovery to patient impact.
NeoMass Biotech 专注于以先进的质谱技术推动新抗原的发现。我们将高分辨率蛋白质组学、免疫肽组学与生物信息学深度融合， 以高精度与高速度识别肿瘤特异性抗原。我们的平台为个体化肿瘤免疫治疗提供稳健且具临床相关性的 新抗原谱，用于疫苗设计、细胞治疗与生物标志物研发。凭借严格的质量控制与转化医学经验， NeoMass Biotech 加速从科研发现走向患者获益的进程。
Ready to collaborate? Reach out to discuss partnerships, pilot projects, or custom analyses.
Email: contact@neomassbiotech.com